Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Edwards Lifesciences Completes Acquisitions of JenaValve Technology and Endotronix
Acquiring Company
Edwards Lifesciences
Acquired Company
JenaValve
Description
Edwards Lifesciences today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation. The company has entered into an agreement to acquire JenaValve Technology, a pioneer in the transcatheter treatment of aortic regurgitation and has exercised its option to acquire Endotronix, a leader in heart failure management solutions.
Fundz sees it the moment Edwards Lifesciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired JenaValve?
JenaValve was acquired by Edwards Lifesciences, based in Irvine. The deal was reported on July 25, 2024. Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is privately held and operates in Manufacturing.
When did Edwards Lifesciences acquire JenaValve?
Edwards Lifesciences's acquisition of JenaValve was reported on July 25, 2024. Edwards Lifesciences today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does JenaValve do?
JenaValve is a medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of aortic regurgitation (AR). It is privately held, operating in Manufacturing, and is based in Irvine.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.